Monosaccharides

Intermediate for β-glucosides; potential PET surface modification reagent

S-(-)-Perillyl alcohol glucoside is a glycoconjugate that has been shown to inhibit β-glucosidase and pancreatic lipase. It is used in the treatment of cancers, such as colorectal cancer, by inhibiting glucose uptake into cells. S-(-)-Perillyl alcohol glucoside may also have anticancer effects by inhibiting glucose transporters and caspases.

3-Pyridinylmethylbeta-D-glucopyranoside is a sugar that can be custom synthesized. It is a white to off-white crystalline powder with an odorless taste and is soluble in water. 3-Pyridinylmethylbeta-D-glucopyranoside is used in the synthesis of glycosides, saccharides, oligosaccharides, and monosaccharides. This compound can also be modified with fluorination or methylation reactions. The use of this product has been shown to produce high purity compounds for use in pharmaceuticals, agrochemicals, and other chemical industries.

1,3,4,6-Tetra-O-acetyl-2-O-nonafluorobutane-sulfonyl-b-D-mannopyranose is a fluorinated saccharide that can be custom synthesized. It is a glycosylated carbohydrate with a 1,3,4,6 tetra acetyl substitution at the 2 position of the b D mannopyranose moiety. The chemical formula for this compound is C12H28O8FS2. It has been shown to have potential as an antihyperglycemic agent and has been found to be active in tumor models.

2-Acetonyl-1,3,4,6-tetra-O-acetyl-2-deoxy-b-D-galactopyranoside is a synthetic sugar that has been modified to contain an acetyl group at the C2 position. The synthesis of this compound is based on the modification of galactose with acetic anhydride. This product has been shown to be resistant to hydrolysis by esterases or glucuronidases and can also inhibit bacterial growth in culture. It is a monosaccharide with a CAS number of 85583-40-7. It is also used as a precursor for the synthesis of complex carbohydrates.

3-O-Triisopropylsilyl-D-galactal is a carbohydrate that belongs to the group of sugars. It is an oligosaccharide with a complex structure, which is synthesized from D-galactal by treatment with triisopropylsilyl chloride in pyridine. 3-O-Triisopropylsilyl-D-galactal is used as a reagent for the methylation and glycosylation of proteins and nucleic acids. This compound has been shown to inhibit the enzyme carboxypeptidase A, which may be due to its ability to act as an inhibitor of carbohydrate binding. 3-O-Triisopropylsilyl-D-galactal has also been shown to bind specifically to erythrocyte membranes, suggesting that it could be used as a potential diagnostic marker for glycogen storage diseases.

D-Glucose (5-13C) is a modification of glucose. It is an oligosaccharide that is used in the synthesis of complex carbohydrates. D-Glucose (5-13C) has been modified by methylation and glycosylation to produce monosaccharides and polysaccharides. This sugar can be fluorinated, which makes it useful for saccharide studies.

2-epi-(-)-emtricitabine is an analog of the nucleoside cytidine, which inhibits the phosphorylation and subsequent degradation of deoxycytidine kinase, thereby blocking the production of the viral DNA polymerase. The compound also inhibits tyrosine kinases, which are enzymes that play a vital role in cell signaling. This inhibition may contribute to its antiviral activity. 2-epi-(-)-emtricitabine has been shown to inhibit human immunodeficiency virus (HIV) replication in vitro and in vivo. It is a prodrug that is converted to emtricitabine, its active form, by deoxycytidine kinase and then hydrolyzed by esterases. 2-epi-(-)-emtricitabine has been shown to be effective against hepatitis B virus and cancer cells.

3,4,6-Tri-O-acetyl-1,2-O-ethoxyethylidene-a-D-fructopyranose is a modified carbohydrate with the chemical formula C 12 H 20 O 8 . It is a white crystalline solid that is soluble in water. 3,4,6-Tri-O-acetyl-1,2-O-ethoxyethylidene-a-Dfructopyranose can be used as a monosaccharide or an oligosaccharide. This compound has been synthesized by methylation and glycosylation of glucose.

D-Xylonic acid lithium salt is a redox potential regulator that belongs to the class of nucleotide phosphate. It has been shown to inhibit the transcriptional regulation of genes in Saccharomyces cerevisiae strain. D-Xylonic acid lithium salt inhibits the growth of bacteria by binding to a hydroxyl group on the surface of bacterial cells, which disrupts the cell membrane and causes cell death. This drug also has film-forming properties and can be used as a model system for studying glycolaldehyde, an intermediate in sugar metabolism.

Ethyl 2,3-di-O-(4-methoxybenzyl)-4,6-O-(4-methoxybenzylidene)-b-D-thiogalactopyranoside is a high purity, custom synthesis sugar that can be modified with fluorination, glycosylation, and methylation. This product has CAS number 401071-27-8. Ethyl 2,3-di-O-(4-methoxybenzyl)-4,6-O-(4-methoxybenzylidene)-b-D-thiogalactopyranoside is an oligosaccharide and monosaccharide of the carbohydrate complex.

3-Deoxy-3-fluoro-D-mannose (3DFM) is a synthetic sugar molecule that acts as an inhibitor of bacterial growth. It binds to the 6-phosphate group of nucleic acids, which prevents the addition of sugar molecules to ribose or deoxyribose groups. 3DFM also inhibits the synthesis of proteins and RNA, which are necessary for bacterial growth. 3DFM is a structural analog of mannose and glucose, and has been shown to be effective against chronic infections caused by bacteria that produce lectins, such as C. difficile. This drug can be used in combination with other antibiotics to enhance their effectiveness.

2-Hydroxyimipramine b-D-glucuronide is a custom synthesis, modification, and fluorination of the drug 2-hydroxyimipramine. The methyl group from the molecule is replaced with a fluoro group. This modification leads to a new compound with improved pharmacokinetic properties. The new compound also has glycosylation sites on the sugar ring that are not present in the parent drug. This modification may lead to an increase in the therapeutic efficacy of 2-hydroxyimipramine b-D-glucuronide as it interacts with other drugs and increases their bioavailability.

Methyl 1-(5-fluoro-1H-2-oxopyrimidin-4-yl)-b-D-glucopyranuronate is an anticancer drug that inhibits β-glucuronidase. Methyl 1-(5-fluoro-1H-2-oxopyrimidin-4-yl)-b-D-glucopyranuronate is a colorless solid that has been recrystallized, purified, and analyzed for its chloride content. The function of this compound has been tested in vitro using tissue cultures and animal models. The reaction vessel used for the test was an acetonitrile solution with a pH between 7 and 8. The methylester form of methyl 1-(5-fluoro-1H--2--oxopyrimidin 4--yl)-b--D--glucopyranuronate reacts with sulphite to produce a green product with a colorimetric method

3'-a-Sialyl-N-acetyllactosamine sodium salt is a high purity, custom synthesis sugar. It has been modified with fluorination, glycosylation, and methylation to provide the desired properties. This product is also available in other forms such as monosaccharide and saccharide. 3'-a-Sialyl-N-acetyllactosamine sodium salt can be used in various applications including Click modification, fluoroamination, glycosylation, carbonylation and methylation. CAS No. 350697-53-9

Tetra-O-acetyl-2-acetamido-2-deoxy-b-D-mannose is a modified sugar that is synthesized by the methylation of 2,4,6-trichloroacetimidate. This compound has been used in the synthesis of glycosylations and other modifications. Tetra-O-acetyl-2-acetamido-2-deoxy-b-D mannose can be custom synthesized to your specifications with high purity.